Now showing items 1-3 of 3

    • Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma. 

      Young, Ken; Xia, Y; Xu-Monette, ZY; Tzankov, A; Li, X; Manyam, GC; Murty, V; ... (33 authors) (Leukemia, 2017-03)
      PRDM1/BLIMP-1, a master regulator of plasma-cell differentiation, is frequently inactivated in activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) patients. Little is known about its genetic aberrations and ...
    • Nanofabrication at high throughput and low cost. 

      Wiley, BJ; Qin, D; Xia, Y (ACS Nano, 2010-07-27)
      The task of nanofabrication can, in principle, be divided into two separate tracks: generation and replication of the patterned features. These two tracks are different in terms of characteristics, requirements, and aspects ...
    • Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. 

      Chen, J; Dai, J; Dong, Jing; Han, J; Han, J; Hu, Z; Jiang, Y; ... (15 authors) (Int J Cancer, 2015-10-01)
      The early detection of hepatocellular carcinoma (HCC) presents a challenge because of the lack of specific biomarkers. Serum/plasma microRNAs (miRNAs) can discriminate HCC patients from controls. We aimed to identify and ...